Literature DB >> 16374883

Fully MR-guided hepatic artery catheterization for selective drug delivery: a feasibility study in pigs.

Jan-Henry Seppenwoolde1, Lambertus W Bartels, Remko van der Weide, Johannes F W Nijsen, Alfred D van het Schip, Chris J G Bakker.   

Abstract

PURPOSE: To demonstrate the feasibility of hepatic catheterization for selective delivery of therapeutic agents using a clinical MRI scanner for real-time image guidance.
MATERIALS AND METHODS: Experiments were performed in three domestic pigs (70-80 kg) using a clinical 1.5-T MR scanner. After abdominal three-dimensional contrast-enhanced MR angiography (3D-CE-MRA) was performed, endovascular devices with susceptibility markers were tracked with passive tracking techniques. Catheters were maneuvered into the primary and secondary hepatic arteries. Selective catheterization was verified using selective time-resolved CE angiography. Paramagnetic microspheres were administered to a different region for each liver. The resulting biodistributions were investigated using MR images.
RESULTS: Successful selective hepatic catheterization was repeatedly demonstrated using passive tracking techniques. 3D-CE-MRA significantly aided the interventional procedure by showing the vascular anatomy, and maximum-intensity projections (MIPs) were used as roadmaps during the interventions. In all cases, microspheres were successfully delivered to the selected regions. The catheters were visualized at a maximum frame rate of five frames per second, allowing a good depiction of the devices and a reliable catheterization of the hepatic arteries.
CONCLUSION: Fully MR-guided real-time navigation of endovascular devices permits complex procedures such as selective intra-arterial delivery of therapeutic agents to parts of the liver. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16374883     DOI: 10.1002/jmri.20479

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Echo-dephased steady state free precession.

Authors:  Sunil Patil; Oliver Bieri; Klaus Scheffler
Journal:  MAGMA       Date:  2009-05-16       Impact factor: 2.310

Review 2.  Interventional CMR: Clinical applications and future directions.

Authors:  Toby Rogers; Robert J Lederman
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

Review 3.  Magnetic Resonance-Guided Passive Catheter Tracking for Endovascular Therapy.

Authors:  Fabio Settecase; Alastair J Martin; Prasheel Lillaney; Aaron Losey; Steven W Hetts
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-08-12       Impact factor: 2.266

4.  MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation.

Authors:  Gerrit H van de Maat; Peter R Seevinck; Mattijs Elschot; Maarten L J Smits; Hendrik de Leeuw; Alfred D van Het Schip; Maarten A D Vente; Bernard A Zonnenberg; Hugo W A M de Jong; Marnix G E H Lam; Max A Viergever; Maurice A A J van den Bosch; Johannes F W Nijsen; Chris J G Bakker
Journal:  Eur Radiol       Date:  2012-09-27       Impact factor: 5.315

5.  Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.

Authors:  M A D Vente; T C de Wit; M A A J van den Bosch; W Bult; P R Seevinck; B A Zonnenberg; H W A M de Jong; G C Krijger; C J G Bakker; A D van het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

6.  Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.

Authors:  M A D Vente; J F W Nijsen; T C de Wit; J H Seppenwoolde; G C Krijger; P R Seevinck; A Huisman; B A Zonnenberg; T S G A M van den Ingh; A D van het Schip
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-11       Impact factor: 9.236

Review 7.  The physics of radioembolization.

Authors:  Remco Bastiaannet; S Cheenu Kappadath; Britt Kunnen; Arthur J A T Braat; Marnix G E H Lam; Hugo W A M de Jong
Journal:  EJNMMI Phys       Date:  2018-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.